Header Logo

Connection

Sue Leurgans to Molecular Targeted Therapy

This is a "connection" page, showing publications Sue Leurgans has written about Molecular Targeted Therapy.
Connection Strength

0.029
  1. Cortical pyroglutamate amyloid-? levels and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36(1):12-9.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.